GT Biopharma (GTBP) had the highest return between 2007 and 2012 by a US stock, returning 371,304,591.5%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2007-2012	371,304,591.46%
Northern Oil & Gas (NOG)	2007-2012	5,425,696.15%
QXO (QXO)	2007-2012	4,032,075%
Future Fintech (FTFT)	2007-2012	3,922,230.1%
Sequans Communications (SQNS)	2007-2012	2,819,177.11%
Sandstorm Gold Ltd N (SAND)	2007-2012	1,891,416.67%
Castellum (CTM)	2007-2012	815,117.39%
Ageagle Aerial Systems (UAVS)	2007-2012	707,899.54%
Natwest (NWG)	2007-2012	678,100%
Metalla Royalty & Streaming (MTA)	2007-2012	569,900%
Ferguson (FERG)	2007-2012	312,979.05%
Ring Energy (REI)	2007-2012	195,233.33%
PharmaCyte Biotech (PMCB)	2007-2012	32,582.86%
Aris Mining (ARMN)	2007-2012	28,707.19%
BioLineRx (BLRX)	2007-2012	24,419.07%
Pioneer Power Solutions (PPSI)	2007-2012	11,111.15%
Intellinetics (INLX)	2007-2012	8,066.67%
Weatherford International (WFRD)	2007-2012	7,600%
Cocrystal Pharma (COCP)	2007-2012	4,233.33%
VirnetX Holding Corp Common Stock (VHC)	2007-2012	3,545.51%
Kandi Technologies (KNDI)	2007-2012	2,560%
Par Pacific (PARR)	2007-2012	1,900%
Intelligent Protection Management (IPM)	2007-2012	1,775.03%
Altisource Portfolio Solutions (ASPS)	2007-2012	1,563.42%
Booking (BKNG)	2007-2012	1,310.62%